Compounds and compositions as protein kinase inhibitors
US8563553B2 · kind B2 · utility
9Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 16, 2012 |
| Grant date | Oct 22, 2013 |
| Priority date | — |
| Expiry date | May 16, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula I or II:wherein R1, R1b, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds of Formula (I) or (II) and pharmaceutical compositions thereof are useful for the treatment of B-Raf-associated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.